Advertisement

Acta Diabetologica

, Volume 55, Issue 9, pp 885–892 | Cite as

The post-HAPO situation with gestational diabetes: the bright and dark sides

  • Annunziata Lapolla
  • Boyd E. Metzger
Review Article
  • 236 Downloads

Abstract

Aim

In 2010, in light of the data coming from the HAPO study, the International Association of Diabetes and Pregnancy Study Groups (IADPSG) proposed a new detection strategy and diagnostic criteria for gestational diabetes based on a one-step approach with a 75 g OGTT. This review analyzes and discusses the bright and dark sides of their application.

Methods

The assessment of these recommendations by the international organizations involved in the care of gestational diabetes and a series of observational, retrospective and prospective studies that have been published since 2010 regarding the use of the IADPSG recommendations have been evaluated.

Results

The different international associations involved in the care of pregnancy and of pregnancy complicated by diabetes have not taken an univocal position some of which have accepted them, while others have criticized them. Then, the actual application of the approach recommended by the IADPSG for detecting and diagnosing GDM varies, even at centers that reportedly accept the new diagnostic criteria.

Conclusion

So the challenge lies in making every effort to achieve a global standardization of the strategies for detecting, diagnosing and treating GDM.

Keywords

Gestational diabetes Diagnostic criteria Maternal outcome Fetal outcome 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interest.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

For this type of study formal consent is not required.

References

  1. 1.
    American Diabetes Association (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care 29(suppl 1):S43–S48Google Scholar
  2. 2.
    Lapolla A, Dalfrà MG, Bonomo M et al (2009) Gestational diabetes mellitus in Italy: a multicenter study. Eur J Obstet Gynecol Reprod Biol 145(2):149–153CrossRefPubMedGoogle Scholar
  3. 3.
    Metzger BE, Lowe P, Dyer AR et al (2008) Hyperglycemia and adverse pregnancy outcomes. New Engl J Med 38:1991–2002Google Scholar
  4. 4.
    Kim C, Newton KM, Knoop RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes care 25:1862–1868CrossRefPubMedGoogle Scholar
  5. 5.
    O’Sullivan JB, Mahan C (1964) Criteria for oral glucose tolerance test in pregnancy. Diabetes 13:436–440CrossRefGoogle Scholar
  6. 6.
    Sermer M, Naylor CD, Gare DJ et al (1995) Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. Am J Obstet Gynecol 173:146–156CrossRefPubMedGoogle Scholar
  7. 7.
    Jensen DM, Damm P, Sørensen B et al (2001) Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am J Obstet Gynecol 185:413–419CrossRefPubMedGoogle Scholar
  8. 8.
    Vambergue A, Nuttens MC, Verier-Mine O et al (2000) Is mild gestational hyperglycaemia associated with maternal and neonatal complications? The Diagest Study. Diabet Med 17:203–208CrossRefPubMedGoogle Scholar
  9. 9.
    Lapolla A, Dalfrà MG, Bonomo M et al (2007) Can plasma glucose and HbA1c predict fetal growth in mothers with different glucose tolerance levels? Diabetes Res Clin Pract 77(3):465–470CrossRefPubMedGoogle Scholar
  10. 10.
    Lapolla A, Bonomo M, Dalfrà MG et al (2010) Prepregnancy BMI influences maternal and fetal outcomes in women with isolated gestational hyperglycaemia: a multicentre study. Diabetes Metab 36(4):265–270CrossRefPubMedGoogle Scholar
  11. 11.
    HAPO Study Cooperative Research Group, Metzger BE, Lowe LP et al (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991–2001CrossRefGoogle Scholar
  12. 12.
    Crowther CA, Hiller JE, Moss JR et al (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352:2477–2486CrossRefPubMedGoogle Scholar
  13. 13.
    Landon MB, Spong CY, Thom E et al (2009) A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 361:1339–1348CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Schmidt MI, Duncan BB, Reichelt AJ et al (2001) gestational diabetes mellitus diagnosed with 75 gr glucose tolerance test and adverse pregnancy outcome. Diabetes Care 24:1151–1115CrossRefPubMedGoogle Scholar
  15. 15.
    International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–682CrossRefPubMedCentralGoogle Scholar
  16. 16.
    Committee Opinion Number 504, American College of Obstetricians and Gynecologists (2011) Screening and diagnosis of gestational diabetes mellitus. Obstet Gynecol 118:751–753CrossRefGoogle Scholar
  17. 17.
    Ryan EA (2011) Diagnosis of gestational diabetes. Diabetologia 54:480–486CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Long H (2011) Diagnosis of gestational diabetes: can expert opinion replace scientific evidence? Diabetologia 54:2211–2213CrossRefPubMedGoogle Scholar
  19. 19.
    Long H, Cundy T (2013) Establishing consensus in the diagnosis of gestational diabetes following HAPO: were do we stand? Curr Diab Res 13:43–50CrossRefGoogle Scholar
  20. 20.
    McIntire HD, Metzger BE, Coustan DR et al (2014) Counterpoint: establishing consensus in the diagnosis of gestational diabetes following the HAPO study. Curr Diab Res 14:497–454CrossRefGoogle Scholar
  21. 21.
    Sacks DA, Hadden DR, Deerochanawong C et al (2012) Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study. Diabetes Care 35:526–528CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Duran A, Saenz S, Torrejon MJ et al (2014) Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnancy woman: the St. Carlos Gestational Diabetes Study. Diabetes Care 37:2442–2450CrossRefPubMedGoogle Scholar
  23. 23.
    Lapolla A, Dalfrà MG, Ragazzi E et al (2011) New International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recommendations for diagnosing gestational diabetes compared with former criteria: a retrospective study on pregnancy outcome. Diabet Med 28(9):1074–1077CrossRefPubMedGoogle Scholar
  24. 24.
    Wery E, Vambergue A, Le Goueff F et al (2014) Impact of the new screening criteria on the gestational diabetes prevalence. J Gynecol Obstet Biol Reprod 43(4):307–313CrossRefGoogle Scholar
  25. 25.
    Mayo K, Melamed N, Vandenberghe H et al (2105) The impact of adoption of the international association of diabetes in pregnancy study group criteria for the screening and diagnosis of gestational diabetes. Am J Obstet Gynecol 212(2):224–228Google Scholar
  26. 26.
    Kong JM, Lim K, Thompson DM (2015) Evaluation of the International Association of the Diabetes In Pregnancy Study Group new criteria: gestational diabetes project. Can J Diabetes 39(2):128–132CrossRefPubMedGoogle Scholar
  27. 27.
    Feldman RK, Tieu RS, Yasumura L (2016) Gestational diabetes screening: the international association of the diabetes and pregnancy study groups compared with Carpenter–Coustan screening. Obstet Gynecol 127(1):10–17CrossRefGoogle Scholar
  28. 28.
    Ogunleye OK, Davidson KD, Gregg AR, Egerman RS (2017) Perinatal outcomes after adopting 1- versus 2-step approach to diagnosing gestational diabetes. J Matern Fetal Neonatal Med 30(2):186–190CrossRefPubMedGoogle Scholar
  29. 29.
    Avalos GE, Owens LA, Dunne F, ATLANTIC DIP Collaborators (2013) Applying current screening tools for gestational diabetes mellitus to a European population: is it time for change? Diabetes Care 36(10):3040–3044CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Donovan LE, Edwards AL, Savu A et al (2017) Population-level Outcomes with a 2-step approach for gestational diabetes screening and diagnosis. Can J Diabetes.  https://doi.org/10.1016/j.jcjd.2016.12.010 CrossRefPubMedGoogle Scholar
  31. 31.
    Sacks DA, Black MH, Li X, Montoro MN, Lawrence JM (2016) Adverse pregnancy outcomes using the international association of the diabetes and pregnancy study groups criteria: glycemic thresholds and associated risks. Obstet Gynecol 126(1):67–73CrossRefGoogle Scholar
  32. 32.
    Waters TP, Dyer AR, Scholtens DM et al (2016) Maternal and neonatal morbidity for woman who would be added to the diagnosis of GDM using IADPSG criteria: a secondary analysis of the hyperglycemia and adverse pregnancy outcome study. Diabetes Care 39:2204–2210CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Mission JF, Ohno MS, Cheng YW, Caughey AB (2012) Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis. Am J Obstet Gynecol 207:326.e1–326.e9CrossRefGoogle Scholar
  34. 34.
    Werner EF, Pettker CM, Zuckerwise L et al (2012) Screening for gestational diabetes mellitus: are the criteria proposed by the international association of the Diabetes and Pregnancy Study Groups cost-effective? Diabetes Care 35(3):529–535CrossRefGoogle Scholar
  35. 35.
    Marseille E, Lohse N, Jiwani A et al (2013) The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel. J Matern Fetal Neonatal Med 26(8):802–810CrossRefPubMedGoogle Scholar
  36. 36.
    Moses RG, Morris GJ, Petocz P, SanGil F (2011) The impact of potential new diagnostic criteria on the prevalence of gestational diabetes mellitus in Australia. Med J Aust 194(7):338–340PubMedGoogle Scholar
  37. 37.
    Agarwal MM, Dhatt GS, Othman Y (2015) Gestational diabetes: differences between the current international diagnostic criteria and implications of switching to IADPSG. J Diabetes Compl 29(4):544–549CrossRefGoogle Scholar
  38. 38.
    Kalter-Leibovici O, Freedman LS, Olmer L, Lieberman N, Heymann A, Orna T, Lerner-Geva L, Hod M (2012) Screening and diagnosis of gestational diabetes mellitus. Diabetes Care 35:1894–1896CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Savona-Ventura C, Vassallo J, Marre M, Karamanos BG; MGSD-GDM study group (2013) A composite risk assessment model to screen for gestational diabetes mellitus among Mediterranean women. Int J Gynaecol Obstet 120(3):240–244CrossRefPubMedGoogle Scholar
  40. 40.
    Yeral MI, Ozgu-Erdinc AS, Uygur D et al (2014) Prediction of gestational diabetes mellitus in the first trimester, comparison of fasting plasma glucose, two-step and one-step methods: a prospective randomized controlled trial. Endocrine 46(3):512–518CrossRefPubMedGoogle Scholar
  41. 41.
    Poomalar GK, Rangaswamy V (2013) A comparison of fasting plasma glucose and glucose challenge test for screening of gestational diabetes mellitus. J Obstet Gynaecol 33(5):447–450CrossRefPubMedGoogle Scholar
  42. 42.
    Ozgu-Erdinc AS, Yilmaz S, Yeral MI et al (2015) Prediction of gestational diabetes mellitus in the first trimester: comparison of C-reactive protein, fasting plasma glucose, insulin and insulin sensitivity indices. J Matern Fetal Neonatal Med 28(16):1957–1962CrossRefPubMedGoogle Scholar
  43. 43.
    Wang C, Zhu W, Wei Y et al (2016) The predictive effects of early pregnancy lipid profiles and fasting glucose on the risk of gestational diabetes mellitus stratified by body mass index. J Diabetes Res 2016:3013357Google Scholar
  44. 44.
    Agarwal MM (2016) Gestational diabetes mellitus: screening with fasting plasma glucose. World J Diabetes 7:279–289CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Agarwal MM, Dhatt GS, Punnose J, Zayed R (2007) Gestational diabetes: fasting and postprandial glucose as first prenatal screening tests in a high-risk population. J Reprod Med 52(4):299–305PubMedGoogle Scholar
  46. 46.
    Corrado F, D’Anna R, Cannata ML et al (2012) Correspondence between first-trimester fasting glycaemia, and oral glucose tolerance test in gestational diabetes diagnosis. Diabetes Metab 38(5):458–461CrossRefPubMedGoogle Scholar
  47. 47.
    Riskin-Mashiah S, Damti A, Younes G, Auslender R (2010) First trimester fasting hyperglycemia as a predictor for the development of gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol 152(2):163–167CrossRefPubMedGoogle Scholar
  48. 48.
    Zhu WW, Yang HX, Wei YM et al (2013) Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in China. Diabetes Care 36(3):586–590CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Popova P, Tkachuk A, Dronova A et al (2016) Fasting glycemia at the first prenatal visit and pregnancy outcomes in Russian women. Minerva Endocrinol 41(4):477–485PubMedGoogle Scholar
  50. 50.
    Jiwani A, Marseille E, Lohse N et al (2012) Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med 25:600–610CrossRefPubMedGoogle Scholar
  51. 51.
    Buckley BS, Harreiter J, Damm P et al (2012) Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review. Diabet Med 29:844–854CrossRefPubMedGoogle Scholar
  52. 52.
    Pintaudi B, Fresa R, Dalfrà M et al (2016) Level of implementation of guidelines on screening and diagnosis of gestational diabetes: a national survey. Diabetes Res Clin Pract 113:48–52CrossRefPubMedGoogle Scholar
  53. 53.
    WHO (2013) Diagnostic criteria and classification of hyperglycemia first detected in pregnancy. World Health Organization, GenevaGoogle Scholar
  54. 54.
    ACOG (2011) Committee opinion no. 504: screening and diagnosis of gestational diabetes mellitus. Obstet Gynecol 18(3):751–753Google Scholar
  55. 55.
    Benhalima K, Van Crombrugge P, Devlieger R et al (2013) Screening for pregestational and gestational diabetes in pregnancy: a survey of obstetrical centers in the northern part of Belgium. Diabetol Metab Syndr 5:66–70CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    American Diabetes Association (2017) Standard of medical care in diabetes. Gestational diabetes mellitus. Diabetes Care 40(1):S11–S24CrossRefGoogle Scholar
  57. 57.
    NICE Guidelines (2015) Diabetes in pregnancy: management from preconception to the postnatal period. https://www.nice.org.uk/guidance.ng3
  58. 58.
    Di CianniG, Gualdani E, Berni C, Meucci A, Roti L, Lencioni C, Lacaria E, Seghieri G, Francesconi P (2017) Screening for gestational diabetes in Tuscany, Italy. A population study. Diab Res Clin pract 132:149–156CrossRefGoogle Scholar
  59. 59.
    Nielsen KK, De Courten M, Kapur A (2012) The urgent need for universally applicable simple screening procedures and diagnostic criteria for gestational diabetes mellitus-lessons from projects funded by the World Diabetes Foundation. Global Health Action 5:1–12CrossRefGoogle Scholar
  60. 60.
    Agarwal MM, Shah SM, Al Kaabi J, Saquib S, Othman Y (2015) Gestational diabetes mellitus: Confusion among medical doctors caused by multiple international criteria. J Obstet Gynaecol Res 41(6):861–869CrossRefPubMedGoogle Scholar
  61. 61.
    Hod M, Kapur A, Sacks DA et al (2015) The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet 131(Suppl 3):S173–S211CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Diabetology and Dietetics Unit, Department of MedicinePadova UniversityPadovaItaly
  2. 2.Division of Endocrinology, Metabolism and Molecular Medicine, Department of MedicineNorthwestern University Feinberg School of MedicineChicagoUSA

Personalised recommendations